Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN101805380B details a scalable acetylation method for nucleoside intermediates, offering significant cost reduction and simplified purification for API manufacturing.
Advanced industrial synthesis of CDB-2914 intermediates via CN101466723B. Offers improved yield, safer temperatures, and scalable pharmaceutical manufacturing solutions.
Novel patent CN102010455A details a high-purity Decitabine route avoiding isomer separation. Ideal for cost reduction in API intermediate manufacturing.
Patent CN102050791B discloses a cost-effective synthesis of telmisartan intermediates using mild conditions, offering supply chain stability and reduced production costs for global manufacturers.
Patent CN109503568A details a high-yield Dasatinib synthesis using ionic liquids and copper catalysis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1031795C reveals a novel boron complex route for 8-alkoxyquinolones, eliminating corrosive HF byproducts and enabling cost-effective pharmaceutical manufacturing.
Patent CN107573333A reveals a mild trifluoroacetyl protection strategy for ticagrelor intermediates, enabling scalable production with reduced energy consumption and waste.
Patent CN106749259B reveals a metal-free synthetic route for CDK4/6 inhibitor intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel ionic liquid catalysis method for high-purity pharmaceutical intermediates with reduced waste and simplified purification ensuring reliable supply chain efficiency.
Patent CN102702292B reveals solvent-free melt condensation for azacitidine. Enhances purity, reduces hydrolysis, and offers significant supply chain cost advantages.
Patent CN102264672A details a scalable route to chiral phenols using Ru-catalyzed transfer hydrogenation, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN1222537C reveals a novel Fmoc-strategy for Eptifibatide synthesis, eliminating toxic HF and reducing cycle time. Ideal for reliable peptide intermediate sourcing.
Patent CN104151283A reveals green ionic liquid catalysis for xanthene derivatives. Offers cost reduction in pharmaceutical intermediates manufacturing and scalable supply.
Patent CN115613061A reveals a green electro-catalytic method for azide-substituted tetrazolo[1,5-a]indole synthesis, offering cost-effective scale-up for pharmaceutical intermediates.
Discover the biomass-derived synthesis of Benvitimod intermediates. This patent offers a green, scalable route with recyclable catalysts for cost-effective pharmaceutical manufacturing.
Patent CN111886235A reveals a continuous flow method for Trazodone. Achieve high purity, reduced toxicity, and scalable API intermediate manufacturing.
Patent CN111138325A reveals a safe, copper-catalyzed route to tetra-substituted Z-beta-sulfonyl enamines using solid SO2 sources, offering reliable pharmaceutical intermediate supply.
Patent CN106045804B enables aqueous asymmetric oxidation. Reduces solvent waste and improves catalyst recovery for pharmaceutical intermediates.
Patent CN116444503A details a rhodium-catalyzed route to chroman derivatives using pyridine triazoles, offering mild conditions and high purity for pharmaceutical manufacturing.
Patent CN102690273A details a robust six-step synthesis of Sildenafil featuring stable intermediates and high yields, offering significant cost reduction in pharmaceutical manufacturing.